UBS Starts Caris Life Sciences Inc (CAI) at Neutral
Tweet
Share
E-mailGet Alerts CAI Hot Sheet
Price: $24.04 --0%
Rating Summary:
12 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 3 | New: 32
Rating Summary:
12 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 3 | New: 32
Join SI Premium – FREE
UBS analyst Douglas Schenkel initiates coverage on Caris Life Sciences Inc (NASDAQ: CAI) with a Neutral rating and a price target of $28.00.
For an analyst ratings summary and ratings history on Caris Life Sciences Inc click here. For more ratings news on Caris Life Sciences Inc click here.
Shares of Caris Life Sciences Inc closed at $24.82 yesterday.
You May Also Be Interested In
- Raymond James Starts Rocket Lab USA (RKLB) at Outperform
- KeyBanc Starts Linde (LIN) at Overweight
- Citi Starts Open House Co., Ltd (3288:JP) (OPPPF) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
